Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-231455
Filing Date
2021-07-30
Accepted
2021-07-30 16:07:21
Documents
7
Effectiveness Date
2021-07-30

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ON FORM S-8 d205566ds8.htm S-8 144529
2 EX-5.1 d205566dex51.htm EX-5.1 11266
3 EX-23.2 d205566dex232.htm EX-23.2 1516
4 EX-99.1 d205566dex991.htm EX-99.1 67742
5 GRAPHIC g205566dsp21.jpg GRAPHIC 4368
6 GRAPHIC g205566dsp22.jpg GRAPHIC 3199
7 GRAPHIC g205566g14f69.jpg GRAPHIC 8684
  Complete submission text file 0001193125-21-231455.txt   248884
Mailing Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-258302 | Film No.: 211132596
SIC: 2836 Biological Products, (No Diagnostic Substances)